# Islet Transplantation Using Campath-1H and Infliximab Induction

> **NCT00175266** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 12 (—)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** alemtuzumab
- **PROCEDURE:** islet transplant
- **DRUG:** infliximab

## Key facts

- **NCT ID:** NCT00175266
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 12 (—)
- **Last updated:** 2009-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00175266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00175266, "Islet Transplantation Using Campath-1H and Infliximab Induction". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00175266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*